已收录 268921 条政策
 政策提纲
  • 暂无提纲
Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors
[摘要] Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown dramatic effects against that tumors harboring EGFR activating mutations in the EGFR intracytoplasmic tyrosine kinase domain and resulted in cell apoptosis. Unfortunately, a number of patients ultimately developed resistance by multiple mechanisms. Thus, elucidation of the mechanism of resistance to EGFR-TKIs can provide strategies for blocking or reversing the situation. Recent studies suggested that redundant kinase activation plays pivotal roles in escaping from the effects of EGFR-TKIs. Herein, we aimed to characterize several molecular events involved in the resistance to EGFR-TKIs mediated by redundant kinase activation.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 肿瘤学
[关键词] EGFR;redundant kinase activation;resistance to EGFR-TKIs [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文